Patients Durability and earlier access could reshape diabetic retinop... This year’s World Sight Day turns global attention to the scale of preventable vision loss
Patients The burden of diabetic vision loss in the West Vision loss associated with diabetes is one of the more prevalent and growing healthcare burdens in the Western world.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.